Continuum Advisory, LLC Immunity Bio, Inc. Transaction History
Continuum Advisory, LLC
- $660 Million
- Q1 2024
A detailed history of Continuum Advisory, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 20,021 shares of IBRX stock, worth $127,333. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,021
Previous 21,243
5.75%
Holding current value
$127,333
Previous $106,000
0.94%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
193Shares Held
66.7MCall Options Held
2.27MPut Options Held
3.23M-
State Street Corp Boston, MA14.2MShares$90.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$86.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.48MShares$22.1 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.55MShares$9.85 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.55B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...